Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Molecular Medicine (Cambridge, Mass.)|January 8, 2014
Systemic administration of a cyclic signal transducer and activator of transcription 3 (STAT3) decoy oligonucleotide inhibits tumor growth without inducing toxicological effectsMalabika Sen, Kathleen Paul, Maria L Freilino, et al.
Theranostics|December 19, 2015
Ultrasound Targeted Microbubble Destruction-Mediated Delivery of a Transcription Factor Decoy Inhibits STAT3 Signaling and Tumor GrowthJonathan A Kopechek, Andrew R Carson, Charles F McTiernan, et al.
Molecular Pharmacology|March 8, 2008
Combined targeting of epidermal growth factor receptor, signal transducer and activator of transcription-3, and Bcl-X(L) enhances antitumor effects in squamous cell carcinoma of the head and neckAmanda L Boehm, Malabika Sen, Raja Seethala, et al.
Epigenetics|October 10, 2019
PTPRT epigenetic silencing defines lung cancer with STAT3 activation and can direct STAT3 targeted therapiesMalabika Sen, Audrey Kindsfather, Ludmila Danilova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2012
Targeting Stat3 abrogates EGFR inhibitor resistance in cancerMalabika Sen, Sonali Joyce, Mary Panahandeh, et al.
Molecular Cancer Therapeutics|April 12, 2012
Antitumor mechanisms of targeting the PDK1 pathway in head and neck cancerNeil E Bhola, Maria L Freilino, Sonali C Joyce, et al.
Cancer Chemotherapy and Pharmacology|October 26, 2016
Toxicity, pharmacokinetics and metabolism of a novel inhibitor of IL-6-induced STAT3 activationBrian F Kiesel, Robert A Parise, Jianxia Guo, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 9, 2016
STAT3 as a Chemoprevention Target in Carcinogen-Induced Head and Neck Squamous Cell CarcinomaNoah D Peyser, Lin Wang, Yan Zeng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2015
Increased Expression of HER2, HER3, and HER2:HER3 Heterodimers in HPV-Positive HNSCC Using a Novel Proximity-Based Assay: Implications for Targeted TherapiesNetanya I Pollock, Lin Wang, Gerald Wallweber, et al.
American Journal of Nuclear Medicine and Molecular Imaging|January 24, 2013
Utility of 3'-[(18)F]fluoro-3'-deoxythymidine as a PET tracer to monitor response to gene therapy in a xenograft model of head and neck carcinomaNeale S Mason, Brian J Lopresti, James Ruszkiewicz, et al.
Pageof 4